Paid Clinical Trials in East Syracuse, NY
As of July 2026, 56 paid clinical trials are recruiting in East Syracuse, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
East Syracuse offers studies at sites including Hematology Oncology Associates of Central New York-East Syracuse for conditions such as Alzheimer Disease, Anatomic Stage II Breast Cancer AJCC v8, Atopic Dermatitis, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in East Syracuse
Trials by drug in East Syracuse
Filter results
Newly added in East Syracuse
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
52 clinical trials
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
[18F]PI-2620 Phase 3 Histopathological Study
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Shield Post-Approval Study Protocol
GEMINI-NSCLC: NSCLC Biomarker Study
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Top Research Study Locations in East Syracuse
Researchers run research studies in East Syracuse, NY at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hematology Oncology Associates of Central New York-East Syracuse | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 11 |
| Hematology Oncology Associates of Central New York | Acinar Cell Carcinoma, Advanced Cancer, B-Cell Non-Hodgkins Lymphoma | 5 |
| Hematology Oncology Associates of Central New York, PC | Breast Cancer, Triple Negative Breast Cancer | 3 |
| Velocity Clinical Research - Syracuse | Diabetic Peripheral Neuropathic Pain, AD, Alzheimer Disease | 3 |
| Child Health Care Associates | Pneumococcal Disease, Pneumococcal Infection | 3 |
| Hematology-Oncology Associates of CNY | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 3 |
| Hematology-Oncology Associates of Central NY, P.C. | Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Esophageal Neoplasms | 3 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease | 2 |
| Galderma Investigational | Atopic Dermatitis, Prurigo Nodularis | 2 |
| Hematology Oncology Association of Central New York | Extensive Stage Small-cell Lung Cancer, Metastatic Castration-resistant Prostate Cancer, Small-cell Lung Cancer | 2 |
| SUNY Upstate Medical University, Upstate Global Health Institute | Pharmacokinetic in Normal Population, Post-Treatment Lyme Disease | 2 |
| Upstate Global Health Institute | COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease | 2 |
| Velocity Clinical Research, Syracuse | Agitation, Alzheimer's Type Dementia, Obesity | 2 |
| Empire Dermatology | Atopic Dermatitis | 1 |
| Hematology Oncology Associates of Central NY | Cancer | 1 |
| Hematology-Oncology Associates of Central New York, PC | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 1 |
| Investigative | Hidradenitis Suppurativa (HS) | 1 |
| Montefiore Medical Center | Advanced Breast Cancer | 1 |
| Specialists One Day Surgery | Lumbar Spinal Stenosis | 1 |
| Syracuse Gastroenterological Associates, P.C. | Colo-rectal Cancer | 1 |
| Velocity Clinical Research | Alzheimer Disease | 1 |
Active & Upcoming Studies in East Syracuse (2026)
Recruiting trials in East Syracuse grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (32 active studies)
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer · Phase 1 · TerSera Therapeutics LLC
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · Phase 3 · Amgen
Neurology & pain (4 active studies)
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Diabetes & metabolic (3 active studies)
- A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
- A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
Vaccines (2 active studies)
- Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease · EARLY_Phase 1 · State University of New York - Upstate Medical University
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Common conditions studied in East Syracuse
- Alzheimer Disease (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Atopic Dermatitis (2 active studies)
- Breast Cancer (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Diabetic Peripheral Neuropathic Pain (2 active studies)
Leading research sponsors in East Syracuse
- Pfizer
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in East Syracuse?
There are approximately 56 recruiting clinical trials in East Syracuse, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in East Syracuse pay participants?
Most recruiting trials in East Syracuse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in East Syracuse?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in East Syracuse?
The most common conditions under active study in East Syracuse include Alzheimer Disease (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Atopic Dermatitis (2), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in East Syracuse?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in East Syracuse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in East Syracuse?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in East Syracuse?
Recruiting research sites in East Syracuse include Hematology Oncology Associates of Central New York-East Syracuse, Hematology Oncology Associates of Central New York, Hematology Oncology Associates of Central New York, PC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in East Syracuse right now?
The largest active categories in East Syracuse are Cancer & tumors (32), Neurology & pain (4), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.